• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    T

    Tohoku Rosai Hospital

    EST. 1954
    787论文总数
    2万引用总数

    论文量&引用量时间轴

    机构学者

    论文(787)

    年份
    起
    –
    止
    排序
    1Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2024 for the Clinical Practice of Inflammatory Bowel Disease-Associated Intestinal Neoplasia (english Version)
    Soichiro Ishihara,Shinji Tanaka,Toshio Uraoka,Yutaka Saito,Hiroyuki Takamaru,Hiroshi Nakase,Makoto Naganuma,Tadakazu Hisamatsu,Toshimitsu Fujii,Minoru Matsuura,Takayuki Matsumoto,Kenji Watanabe,

    The number of patients with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), continues to increase in many countries and regions. With recent rapid advances in medical therapies targeting intestinal inflammation, the number of patients with long-term disease duration is also increasing. It is well-recognized that longstanding IBD carries an increased risk of developing gastrointestinal (GI) neoplasia, particularly colorectal cancer. However, compared to sporadic GI tumors, IBD-associated GI tumors are relatively rare, and even among specialists in GI diseases, opportunities to encounter such cases remain limited. In light of this situation, the Japanese Society for Cancer of the Colon and Rectum (JSCCR), in collaboration with the Japanese Inflammatory Bowel Disease Research Group (funded by the Japan Sciences Research Grant for Research on Intractable Diseases affiliated with the Ministry of Health, Labour, and Welfare) launched the Guideline Development Committee for IBD-associated Gastrointestinal Tumors in 2021, with the aim of establishing clinical practice guidelines to support the diagnosis and management of these tumors. The committee-comprising experts in gastroenterology, surgery, pathology, guideline development, and literature review-conducted extensive discussions and successfully published the first Japanese edition of the guidelines in July 2024. We believe that the current edition provides the best possible guidance based on presently available knowledge. Furthermore, the guideline development process highlighted several key issues to be addressed in future research and clinical practice. We are pleased to present here the English version of the JSCCR Guidelines 2024 for the Clinical Practice of IBD-associated Intestinal Neoplasia.

    2026Journal of the anus, rectum and colon(2026)引用:2
    引用
    AI阅读
    加入学术空间
    2Shifting Paradigms: How the Glenoid Track Changed the Concept of Shoulder Instability
    Eiji Itoi,Nobuyuki Yamamoto

    Historically, glenoid bone loss and humeral head defects (Hill-Sachs lesions) were evaluated independently. However, the clinical significance of a Hill-Sachs lesion depends on the morphology of the glenoid: an identical lesion may remain stable with an intact glenoid but become unstable in the presence of glenoid bone loss. Therefore, both lesions must be assessed simultaneously. Traditional dynamic intraoperative examination has an inherent limitation. Engagement can be accurately assessed only after Bankart repair (post-repair examination), whereas remplissage, when required, must be performed before the repair (pre-repair examination). To overcome this dilemma, the ‘glenoid track’ concept was introduced, enabling combined assessment of Hill-Sachs lesions and glenoid bone loss. Since its introduction, the concept has evolved through refinements such as consideration of subcritical glenoid bone loss, subdivision into central and peripheral tracks, and patient-specific adjustment of track width based on the range of motion. Efforts are also underway to establish accurate MRI-based assessment, facilitating widespread radiation-free application. Furthermore, the concept has been extended to posterior shoulder instability through the development of the ‘reverse glenoid track’ concept, broadening its applicability across the spectrum of shoulder instability.

    2026International Orthopaedics(2026)引用:1
    引用
    AI阅读
    加入学术空间
    3Trends in Clinical and Basic Research on Rotator Cuff Tears in Japan.
    Nobuyuki Yamamoto,Eiji Itoi

    Research on rotator cuff tears in Japan was initially characterized by studies clarifying prevalence, asymptomatic tears, and natural history. It subsequently developed toward evaluation of outcomes after arthroscopic repair, postoperative tendon integrity, and long-term results of conservative treatment. This article reviews clinical and basic research on rotator cuff tears that has been conducted in Japan. Representative examples include arthroscopic superior capsule reconstruction (SCR), rotator cuff reconstruction combined with small-head hemiarthroplasty, arthroscopic muscle advancement, and infraspinatus rotational transfer. More recently, basic research on rotator cuff tears in Japan has shifted its focus from simply how to repair the torn tendon to how closely the tendon-bone insertion can be regenerated toward its native structure, and what biological and mechanical conditions can reduce retear. Because reverse total shoulder arthroplasty (rTSA) was introduced in Japan in 2014, later than in many other countries, several Japan-specific surgical techniques for massive rotator cuff tears were developed during the preceding period.

    2026International Orthopaedics(2026)引用:1
    引用
    AI阅读
    加入学术空间
    4Location and Size of the Glenoid Defect in Patients with Traumatic Posterior Shoulder Instability
    Kaijia Yang,Nobuyuki Yamamoto,Norimasa Takahashi,Hideki Kamijo,Kenji Okamura,Teruhisa Mihata,Hiroyuki Sugaya,Tadanao Funakoshi,Atsushi Arino,Jun Kawakami,Toshimi Aizawa,Eiji Itoi

    Background The size and location of the glenoid defect have been extensively studied in patients with anterior shoulder instability. However, in patients with traumatic posterior instability, little is known regarding the location and size of the bony defect of the glenoid. The purpose of the present study was to clarify the location and extent of the glenoid defect in shoulders with traumatic posterior instability with use of CT images. Methods Forty-three shoulders of 42 patients with traumatic posterior instability treated at 7 hospitals were included. Three-dimensional images of the glenoid reconstructed from computed tomography were assessed using image analysis software. The location and size of the glenoid defect were investigated and described on a clock face of the glenoid. Results Thirty-eight of 43 shoulders (88 %) had a glenoid bony defect. Eleven shoulders (26 %) had a bony fragment. The defect width of the glenoid was 2.5 ± 1.3 mm (mean ± standard deviation), which was equivalent to 9.1 ± 5.3 % of the glenoid width. The mean orientation of the defect was pointing toward 8:12, at a mean angle of 246° ± 13.2° from the 12-o'clock direction in the right shoulder. The glenoid defects were located between 5:37 and 10:38. Conclusion The prevalence of the glenoid bony defect in patients with traumatic posterior shoulder instability was as high as that in patients with anterior shoulder instability. However, its size was smaller than the anterior instability and it was located posteroinferiorly. IRB approval #2022-1-1168.

    2026Journal of orthopaedic science official journal of the Japanese Orthopaedic Association(2026)引用:1
    引用
    AI阅读
    加入学术空间
    5Irradiated Polyglactin 910 (vicryl Rapide) for Intranasal Mucosal Closure: Rapid Suture Clearance Without Wound Complications
    Kazuhiro Nomura,Yuri Nomura,Tomotaka Hemmi,Risako Kakuta,Toshimitsu Kobayashi

    Background Standard Vicryl sutures on the lateral nasal wall and septum show half-lives of 70 and 64 days, causing crusting, obstruction, irritation, and odor. Irradiated Vicryl Rapide absorbs faster.Aims We aimed to evaluate the clinical usefulness of Vicryl Rapide for mucosal suturing in the nasal cavity by assessing wound status and suture clearance.Methods This retrospective study included 36 consecutive patients who underwent septoplasty, and/or inferior turbinectomy, and/or endoscopic modified medial maxillectomy (EMMM) with Vicryl Rapide mucosal closure between October 2025 and March 2026. Suture clearance was defined as the clinical absence of visible suture material on nasal endoscopy. Wound infection and dehiscence were recorded at outpatient visits. Remaining suture threads were counted at each visit.Results No wound infection or dehiscence was observed. Model-estimated median suture clearance time was 15.4 days (95% CI: 14.2-16.6) on the nasal septum and 14.6 days (95% CI: 13.6-15.5) on the lateral nasal wall, with no significant difference between sites (p = 0.093). The maximum observed suture persistence was 19 days on the nasal septum and 21 days on the lateral nasal wall.Conclusions and Significance Vicryl Rapide achieved short-term mucosal closure without observed infection or dehiscence in this series. (sic)(sic):(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)70(sic)(sic)64(sic), (sic)(sic)(sic)(sic)(sic),(sic)(sic),(sic)(sic)(sic)(sic)(sic).(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(Vicryl Rapide)(sic)(sic)(sic)(sic).(sic)(sic):(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic), (sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic).(sic)(sic):(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)2025(sic)10(sic)(sic)2026(sic)3(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic),(sic)/(sic)(sic)(sic)(sic)(sic)(sic)(sic),(sic)/(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(EMMM)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)36(sic)(sic)(sic)(sic)(sic).(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic).(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic).(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic).(sic)(sic):(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic).(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic) 15.4 (sic)(95% CI:14.2-16.6), (sic)(sic)(sic)(sic)(sic) 14.6 (sic)(95% CI:13.6-15.5), (sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(p=0.093).(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic) 19 (sic), (sic)(sic)(sic) 21 (sic).(sic)(sic)(sic)(sic)(sic):(sic)(sic)(sic)(sic)(sic)(sic)(sic), (sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic), (sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic)(sic).

    2026ACTA OTO-LARYNGOLOGICA(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 787 篇论文

    合作机构(100)

    东北大学(日本)合作论文 277
    Tohoku University Hospital合作论文 56
    东京大学合作论文 31
    Sendai Medical Center,National Hospital Organization合作论文 28
    九州大学合作论文 27
    大崎市民病院合作论文 27
    庆应义塾大学合作论文 25
    岩手医科大学合作论文 25
    帝京大学合作论文 24
    京都大学合作论文 23

    机构统计